EK

ELIZABETH KARAN

ARTEMIS POLICY GROUP LLC · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
3
last 3 years
Filings
8
16 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Washington, DC
2024 - present

Specific issues

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3851/S. 2464) Safe Step Act (H.R.2630/S. 652) Implementation of the Affordable Care Act HELP Copays Act (H.R.830/S.1375) Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Find It Early Act (H.R.3086/S.5141); a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Policies related to coverage of preventive services with no cost-sharing Polices regarding White House Cancer Moonshot implementation Policies related to copay accumulator and maximizer adjustors H.J. Res. 181, Congressional Review Act resolution to stop the Biden-Harris rule limiting access to Association Health Plans (AHPs) Policies related to the extension of enhanced advanced premium tax credits Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) H.R. 1692 - Health Care Affordability Act of 2023; a bill to revise the tax credit for health care premium assistance to expand the eligibility of low-income taxpayers for such credit and reduce the cost of health care premiums S. 8 - Improving Health Insurance Affordability Act of 2023; a bill to expand the eligibility of taxpayers for the refundable tax credit for coverage under a qualified health plan and increases cost-sharing subsidies under the Patient Protection and Affordable Care Act
Insurance · 2024 Q3
Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging FY25 House and Senate Labor-HHS Appropriations bills (H.R. 9029/S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025) Policies related to report language on the implementation of the Medicare Prescription Payment Plan. Policies related to the transparent use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening.
Budget/Appropriations · 2024 Q3
Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices, including comments on the proposed rule to regulate Medical Devices; Laboratory Developed Tests The Patent Eligibility Restoration Act (S.2140) Policies related to ICD-10 code for inflammatory breast cancer Comments in response to Congressional Next-Generation Cures package Comments in response to the House Energy & Commerce Committee Framework for Discussion on Reforming the National Institutes of HealthProhibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V) (CFPB-2024- 0023) Comments in response to Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies (FDA-2021D-0789)
Health Issues · 2024 Q3
Metastatic Breast Cancer Access to Care Act (S. 663 / HR 549) Medicare coverage policy for breast cancer treatments and services Telehealth Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing H.R.3086/S.5141 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals Medicaid unwinding, the process for redetermination of Medicaid eligibility Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Community Health Worker Access Act which is a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs (S. 3892) Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Comments in response to CY 2025 Medicare Physician Fee Schedule Comments in response to CY 2025 Medicare HOPPS proposed rule
Medicare/Medicaid · 2024 Q3
Outreach to the Dr. Bertagnolli, NIH Director, and the Office of the Director
Medical/Disease Research/Clinical Labs · 2024 Q3
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 830/S.1375) Private insurance policies that discriminate coverage for high cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) AIMED Alliance Citizens Petition re drug importation and alternative payment models
Insurance · 2024 Q3

Clients

2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q3
SUSAN G. KOMEN
Q3lda.gov →
2024 Q3
THE HEMOPHILIA ALLIANCE
Q3lda.gov →
2024 Q2
SUSAN G. KOMEN
Q2lda.gov →
2024 Q2
THE HEMOPHILIA ALLIANCE
Q2lda.gov →
2024 Q1
CHILD NEUROLOGY FOUNDATION
1Tlda.gov →
2024 Q1
SUSAN G. KOMEN
Q1lda.gov →
2024 Q1
CHILD NEUROLOGY FOUNDATION
Q1lda.gov →
2024 Q1
THE HEMOPHILIA ALLIANCE
Q1lda.gov →
Showing recent filings · full history on lda.gov